Insulin resistance, a prominent pathogenic mechanism in T2DM, results from abnormalities in insulin signaling pathways at various levels, including the insulin receptor, insulin receptor substrate phosphorylation, and the postreceptor signaling pathways, leading to inadequate insulin responsiveness (Eddouks et al., 2014). The gene discussed is INS; the disease is Insulin resistance.